Related Experiment Video
Updated: Nov 21, 2025

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity
Published on: July 12, 2018
The GCN5: its biological functions and therapeutic potentials
Md Ezazul Haque1, Md Jakaria1, Mahbuba Akther1
1Department of Applied Life Science, Graduate School, BK21 Program, Konkuk University, Chungju 27478, Republic of Korea.
General control non-depressible 5 (GCN5), a key histone acetyltransferase, regulates crucial biological processes. Understanding GCN5
Area of Science:
- Epigenetics and Molecular Biology
- Biochemistry
- Medicinal Chemistry
Background:
- General control non-depressible 5 (GCN5), also known as lysine acetyltransferase 2A (KAT2A), is a critical histone acetyltransferase (HAT) and lysine acetyltransferase (KAT).
- GCN5 plays a fundamental role in epigenetic regulation, influencing chromatin structure and gene expression.
- Dysregulation of GCN5 activity is implicated in various pathologies, including cancer, metabolic, autoimmune, and neurological disorders.
Purpose of the Study:
- To provide a comprehensive review of GCN5's structural features and biological functions.
- To elucidate the mechanistic links between GCN5 imbalance and disease progression.
- To examine current GCN5 modulators and their limitations from a medicinal chemistry standpoint.
Main Methods:
- Literature review focusing on structural biology, molecular mechanisms, and disease associations of GCN5.
- Analysis of existing studies on GCN5 modulators and their therapeutic potential.
- Medicinal chemistry perspective on the development and limitations of GCN5-targeting agents.
Main Results:
- GCN5's dual HAT/KAT activity is central to its role in chromatin modification and gene regulation.
- Imbalances in GCN5 are mechanistically linked to the pathogenesis of diverse diseases.
- Current GCN5 modulators show promise but face limitations in specificity and efficacy.
Conclusions:
- A thorough understanding of GCN5's structure-function relationship is essential for disease intervention.
- Targeting GCN5 offers a promising avenue for novel therapeutic strategies across multiple disease areas.
- Further medicinal chemistry efforts are needed to develop more effective and specific GCN5 modulators.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
10:44Chemical Inactivation of the E3 Ubiquitin Ligase Cereblon by Pomalidomide-based Homo-PROTACs
Published on: May 15, 2019
Related Concept Videos
G Protein-coupled Receptors
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Gene Therapy
GPCRs Regulate Adenylyl Cylase Activity
Transducer Mechanism: G Protein–Coupled Receptors
GPCRs are also called heptahelical,...
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Direct-Acting Cholinergic Agonists: Therapeutic Uses